Purchase Order 36C24623P1591
Award Date
8/18/23
Potential Completion Date
9/15/23
Potential Value
$149K
Federal Agency
Veterans Integrated Service Network 6
Awardee
Accredo Health Group, Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bartlett, TN 38134, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) awarded a firm fixed price purchase order contract to Accredo Health Group, Inc., a for-profit pharmacy benefit management company, to provide OXERVATE 0.002% eye drops. The contract has a potential value of $149,388.16 and a completion date of June 30, 2023. As a prime contractor, Accredo Health Group supports the VHA by delivering specialty pharmaceutical products to VA medical centers and facilities nationwide....
The U.S. Department of Veterans Affairs (VA) awarded a firm fixed-price purchase order contract to Accredo Health Group, Inc., a subsidiary of Express Scripts, to provide OXERVATE 0.002% OPTH DROPS 1 ML 7'S 7ML 2 PACK, a specialty pharmaceutical product. The $74,694.08 contract has an ultimate completion date of March 31, 2025 and was awarded on January 10, 2023 through the VA's Veterans Integrated Service Network 21 (VISN 21). The contract is not designated as a set-aside. Accredo Health Group,...
The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) awarded a firm fixed price purchase order contract to Accredo Health Group, Inc. to provide OXERVATE eye drop medication. FDA approval for OXERVATE was granted in 2018 to the manufacturer, Dompe, an Italian company. Accredo Health Group, a specialty pharmacy services provider, is an authorized distributor of OXERVATE. The contract, valued at $140,264.96, does not have a set-aside designation and was awarded on July 1,...
This federal contract award, valued at $80,409.58, was issued by the Department of Veterans Affairs' Veterans Integrated Service Network 19 (VISN 19) to Accredo Health Group, Inc., a for-profit pharmacy benefit management company and subsidiary of Express Scripts. The contract is a firm fixed-price purchase order for the delivery of 9 pharmacy orders across multiple VISN locations, including medications to treat conditions such as pulmonary arterial hypertension, neuropathic lysosomal storage...
This is a $32,078.04 firm fixed-price purchase order awarded by the U.S. Department of Veterans Affairs (VA) to Accredo Health Group, Inc., a specialty pharmacy services provider. The contract, which does not have a set-aside designation, is for the delivery of various high-value medications to support the VA's healthcare services for veterans, including treatments for conditions such as pulmonary arterial hypertension, neuropathic lysosomal storage disorders, and ophthalmic disorders....
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 6 (VHA VISN 6) awarded a $184,877.16 firm fixed price purchase order to Accredo Health Group, Inc. to deliver TYVASCO 0.6 MG REFILL medication. The contract has a period of performance through January 31, 2024. No set-aside designation was used for this award to the prime contractor Accredo Health Group, Inc. located in Bartlett, Tennessee. The VHA VISN 6 oversees healthcare services for...
This is a firm fixed-price purchase order awarded by the Veterans Integrated Service Network 19 (VISN 19) of the U.S. Department of Veterans Affairs (VA) to Accredo Health Group, Inc., a for-profit pharmacy benefit management company. The contract is for the express delivery of second quarter pharmacy orders with a ceiling value of $86,938.57 and a completion date of July 24, 2017. Accredo Health Group, Inc. is a key distributor of complex and high-value medications, primarily serving the...
This is a $113,770.56 firm fixed price purchase order contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Accredo Health Group, Inc., a for-profit pharmacy benefit management company. The contract is for the delivery of TYVASCO 0.6 MG, a specialty pharmaceutical product, to support veterans' healthcare through the VA's Veterans Integrated Service Network 21. The contract does not have a set-aside designation and will be performed at Accredo's...
This federal contract award, with the ID VA25917E0551, was issued by the Department of Veterans Affairs (VA) to the prime contractor Accredo Health Group, Inc., a for-profit pharmacy benefit management company specializing in specialty pharmaceutical services. The award consists of 13 firm fixed-price purchase orders totaling $108,039.41, with an ultimate completion date of September 30, 2016. The contract does not have a set-aside designation. Accredo Health Group, Inc. has been a long-standing...
The U.S. Department of Veterans Affairs (VA) awarded a $81,342.18 firm fixed-price purchase order contract to Accredo Health Group, Inc., a for-profit pharmacy benefit management company, to provide the specialty pharmaceutical TYVASO. The contract, which does not have a set-aside designation, is to support the VA's Veterans Integrated Service Network 21 (VISN 21) and has an ultimate completion date of September 30, 2022. Accredo Health Group, Inc. is a key distributor of complex and...